Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||
7 June 2005 | Volume 142 Issue 11 | Pages 926-931
Although thyroid nodules are common, few are malignant and require surgical treatment. A systematic approach to their evaluation is important to avoid unnecessary surgery. Fine-needle aspiration biopsy has resulted in substantial improvements in diagnostic accuracy, cost reductions, and higher malignancy yield at time of surgery. The preferred approach when repeated fine-needle aspiration biopsy fails to yield an adequate specimen remains a challenge. Management of patients with nodules "suspicious for follicular neoplasm" is difficult, since only 15% to 20% of such lesions have been shown to be malignant. Immunohistochemical markers, such as galectin-3 and human bone marrow endothelial cell (HBME-1), have shown promise in preliminary studies. Routine calcitonin measurement in patients with thyroid nodules has been advocated for early detection of medullary thyroid cancer. However, the low frequency of this cancer, coupled with the high cost associated with case detection, has resulted in a lack of general acceptance of this recommendation.
Author and Article Information
From the Mayo Clinic College of Medicine, Rochester, Minnesota.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: M. Regina Castro, MD, Mayo Clinic, 200 First Street SW, Rochester, MN 55902; e-mail, castro.regina{at}mayo.edu.
Current Author Addresses: Drs. Castro and Gharib: Mayo Clinic, 200 First Street SW, Rochester, MN 55902. REVIEW
Continuing Controversies in the Management of Thyroid Nodules
![]()
This article has been cited by other articles:
![]() |
Y. Erbil, U. Barbaros, A. Salmaslioglu, O. Mete, H. Issever, S. Ozarmagan, D. Yilmazbayhan, and S. Tezelman Effect of Thyroid Gland Volume in Preoperative Detection of Suspected Malignant Thyroid Nodules in a Multinodular Goiter Arch Surg, June 1, 2008; 143(6): 558 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Yeung and J. W. Serpell Management of the Solitary Thyroid Nodule Oncologist, February 1, 2008; 13(2): 105 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Verga, S. Ferrero, L. Vicentini, T. Brambilla, V. Cirello, M. Muzza, P. Beck-Peccoz, and L. Fugazzola Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia? Endocr. Relat. Cancer, June 1, 2007; 14(2): 393 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Costante, D. Meringolo, C. Durante, D. Bianchi, M. Nocera, S. Tumino, U. Crocetti, M. Attard, M. Maranghi, M. Torlontano, et al. Predictive Value of Serum Calcitonin Levels for Preoperative Diagnosis of Medullary Thyroid Carcinoma in a Cohort of 5817 Consecutive Patients with Thyroid Nodules J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 450 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Chia, M. Milas, S. K. Reddy, A. Siperstein, M. Skugor, J. Brainard, and M. K. Gupta Thyroid-Stimulating Hormone Receptor Messenger Ribonucleic Acid Measurement in Blood as a Marker for Circulating Thyroid Cancer Cells and Its Role in the Preoperative Diagnosis of Thyroid Cancer J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 468 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cappelli, M. Castellano, I. Pirola, D. Cumetti, B. Agosti, E. Gandossi, and E. Agabiti Rosei The predictive value of ultrasound findings in the management of thyroid nodules QJM, January 1, 2007; 100(1): 29 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E Bufalo, J. L Leite, A. C T Guilhen, E. C Morari, F. Granja, L. V M Assumpcao, and L. S Ward Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants Endocr. Relat. Cancer, December 1, 2006; 13(4): 1185 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Boelaert, J. Horacek, R. L. Holder, J. C. Watkinson, M. C. Sheppard, and J. A. Franklyn Serum Thyrotropin Concentration as a Novel Predictor of Malignancy in Thyroid Nodules Investigated by Fine-Needle Aspiration J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4295 - 4301. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Lubitz, S. K. Ugras, J. J. Kazam, B. Zhu, T. Scognamiglio, Y.-T. Chen, and T. J. Fahey III Microarray Analysis of Thyroid Nodule Fine-Needle Aspirates Accurately Classifies Benign and Malignant Lesions J. Mol. Diagn., September 1, 2006; 8(4): 490 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
L D K E Premawardhana and J H Lazarus Management of thyroid disorders. Postgrad. Med. J., September 1, 2006; 82(971): 552 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Maier, H. van Steeg, C. van Oostrom, S. Karger, R. Paschke, and K. Krohn Deoxyribonucleic Acid Damage and Spontaneous Mutagenesis in the Thyroid Gland of Rats and Mice Endocrinology, July 1, 2006; 147(7): 3391 - 3397. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Niedziela Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr. Relat. Cancer, June 1, 2006; 13(2): 427 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Roti, R. Rossi, G. Trasforini, F. Bertelli, M. R. Ambrosio, L. Busutti, E. N. Pearce, L. E. Braverman, and E. C. degli Uberti Clinical and Histological Characteristics of Papillary Thyroid Microcarcinoma: Results of a Retrospective Study in 243 Patients J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2171 - 2178. [Abstract] [Full Text] [PDF] |
||||
Read all Rapid Responses